MAPKAP kinase 2 inhibitors (Merck)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMAPKAP kinase 2 inhibitors (Merck)
Drug Alias NameMK-2 inhibitors (Merck)MAPKAPK-2 inhibitors (Merck)MK-2684
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-activated protein kinase 2 inhibitors
TargetsMAP kinase-activated protein kinase 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A